Dermatology Program(s)

About Afecta Pharmaceuticals

Afecta Pharmaceuticals is a private, pre-revenue biotech leveraging a proprietary technology platform to discover and develop precision small molecule drugs. Its pipeline spans neurology, ophthalmology, oncology, and dermatology, with programs in early clinical stages. Founded by physician-scientists and led by industry veterans, the company employs a collaborative business model, having previously licensed its first discovered drugs to Supernus Pharmaceuticals and listing several major pharma companies as industry partners.

Therapeutic Areas